Joseph Nancy M, Pineda Caryll, Rabban Joseph T
Department of Pathology, University of California San Francisco, San Francisco, California.
Int J Gynecol Pathol. 2018 Mar;37(2):191-197. doi: 10.1097/PGP.0000000000000395.
DNA genotyping is the gold standard diagnostic test to distinguish hydatidiform moles from nonmolar but morphologically abnormal products of conception (POC). The test is based on comparison of alleles at 15 short tandem repeat loci in the chorionic villi of the POC to those in the maternal decidual tissue. If alleles in the POC are not present in the decidua, then the most concerning interpretation is that the POC has a paternal uniparental genome diagnostic of a complete hydatidiform mole (CHM). However, a nonmolar pregnancy from a donated egg would also appear the same because the maternal genome of the POC would match that of the maternal donor, not that of the decidua of the individual carrying the pregnancy. Not surprisingly, 2 cases of potential misclassification of the genotype of a donor egg POC as CHM have been reported in the literature. We hypothesize that the ratio of heterozygous loci to homozygous loci (so-called allele zygosity ratio) distinguishes the genotype of a donor egg POC from CHM. We compared the allele zygosity ratio in 11 nonmolar donor egg POC, 5 dispermic (heterozygous) CHM and 31 monospermic (homozygous) CHM, without knowledge of the use of a donor egg, the histologic findings, or results of p57 immunohistochemical staining. In all 47 cases, the alleles from the chorionic villi did not match those in the decidua. The average ratio of heterozygous to homozygous loci was 4:1 in donor egg POC and 1:3 in dispermic CHM (P<0.0001). Monospermic CHM contained 100% homozygous loci. p57 staining was intact in all donor egg POC. We conclude that the allele zygosity ratio is important to evaluate when interpreting the genotype of morphologically abnormal POC that does not match the genotype of the decidua. A high heterozygous:homozygous ratio should raise concern for a nonmolar donor egg pregnancy. Correlation of this variable along with review of the histologic findings and p57 immunohistochemistry may prevent misclassification of the genotype of a donor egg POC with abnormal villous morphology as a dispermic (heterozygous) CHM.
DNA基因分型是区分葡萄胎与非葡萄胎但形态学异常的妊娠产物(POC)的金标准诊断测试。该测试基于比较POC绒毛膜绒毛中15个短串联重复序列位点的等位基因与母体蜕膜组织中的等位基因。如果POC中的等位基因在蜕膜中不存在,那么最值得关注的解释是POC具有父系单亲基因组,诊断为完全性葡萄胎(CHM)。然而,来自捐赠卵子的非葡萄胎妊娠也会呈现相同情况,因为POC的母体基因组将与母体捐赠者的基因组匹配,而不是与怀有该妊娠的个体的蜕膜基因组匹配。毫不奇怪,文献中已报道了2例将捐赠卵子POC的基因型误分类为CHM的病例。我们假设杂合位点与纯合位点的比例(所谓的等位基因纯合度比例)可区分捐赠卵子POC与CHM的基因型。我们比较了11例非葡萄胎捐赠卵子POC、5例双精子(杂合)CHM和31例单精子(纯合)CHM中的等位基因纯合度比例,且不知晓是否使用了捐赠卵子、组织学检查结果或p57免疫组化染色结果。在所有47例病例中,绒毛膜绒毛中的等位基因与蜕膜中的等位基因不匹配。捐赠卵子POC中杂合位点与纯合位点的平均比例为4:1,双精子CHM中为1:3(P<0.0001)。单精子CHM含有100%的纯合位点。所有捐赠卵子POC中的p57染色均完整。我们得出结论,在解释形态学异常且与蜕膜基因型不匹配的POC的基因型时,等位基因纯合度比例很重要。高杂合:纯合比例应引起对非葡萄胎捐赠卵子妊娠的关注。将此变量与组织学检查结果及p57免疫组化结果相结合进行审查,可以防止将具有异常绒毛形态的捐赠卵子POC的基因型误分类为双精子(杂合)CHM。